2023
DOI: 10.4103/lungindia.lungindia_556_22
|View full text |Cite
|
Sign up to set email alerts
|

New treatments for Drug Resistant TB

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Interest in MTBC typing is further reinforced by the growing global threat posed by M. tuberculosis strains with multidrug resistance (MDR) and/or extensively drug resistance (XDR). [3]…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Interest in MTBC typing is further reinforced by the growing global threat posed by M. tuberculosis strains with multidrug resistance (MDR) and/or extensively drug resistance (XDR). [3]…”
Section: Introductionmentioning
confidence: 99%
“…Interest in MTBC typing is further reinforced by the growing global threat posed by M. tuberculosis strains with multidrug resistance (MDR) and/or extensively drug resistance (XDR). [3] Cuba is one of the 15 countries with the lowest burden of the disease in the Americas region [4] and is working steadily to eliminate TB. In 2022, the WHO estimated a total incidence rate of 6.6 cases of TB per 100,000 inhabitants, with 83% of pulmonary TB being bacteriologically confirmed.…”
Section: Introductionmentioning
confidence: 99%